9) Metabolic Diseases Flashcards
Essential elements of communication in medical encounters: the Kalamazoo Consensus statement
(1) Build the doctor-patient relationship
(2) Open the discussion
(3) Gather information
(4) Understand the patient’s perspective
(5) Share information
(6) Reach agreement on problems and plans
(7) Provide closure
Metabolic diseases
- Fibromyalgia
- Paget’s disease
- Osteoporosis
- Osteomalacia and Rickets
- Hyperparathyroidism and renal osteodystrophy
- Acromegaly
Fibromyalgia high-yield facts
- Etiology unknown
- Fatigue likely from sleep disturbance
- 90% female, 20 to 60 years
- Diagnosis with clinical examination
- Currently no specific diagnostic laboratory test or biomarker available for diagnosis
Fibromyalgia treatment
- Patient education
- Antidepressants
- Sleep modification
Fibromyalgia host factors
- Female predominance 9:1
Fibromyalgia disease process
- Poorly understood
- Not inflammatory in nature
Fibromyalgia symptoms
- Widespread pain above and below the waist on both sides of the body
- Associated with stiffness, fatigue, and sleep disturbance
Fibromyalgia physical exam
- Presence of 11 or more of 18 tender point sites
Fibromyalgia associated features
- Irritable bowel syndrome
- Tension headaches
- Paresthesias
- Sensation of swollen hands
Fibromyalgia laboratory tests
- Normal erythrocyte sedimentation rate (ESR)
- Complete blood count (CBC)
- Chemistries
Fibromyalgia tender point sites (bilateral)
- Occiput (suboccipital muscle insertion)
- Low cervical (anterior intertransverse spaces C5-7)
- Trapezius (midpoint of upper border)
- Supraspinatus (midpoint of upper border)
- Second rib (2nd costochondral jxn, just lateral to jxns on upper surfaces)
- Lateral epicondyle (2cm distal to epicondyles)
- Gluteal (upper outer quadrants in anterior fold os muscle)
- Greater trochanter (posterior to trochanteric prominence)
- Knee (medial fat pas proximal to joint line)
Digital palpation for tender points in fibromyalgia should be performed with an approximate force of
- Four kilograms
- Patient must state palpation was painful to a tender point to be considered “positive”
Management of fibromyalgia
- Patient education
- Psychosocial support
- ID and minimize stress factors
- Moderate exercise (avoid overexertion)
- Relaxation techniques to avoid muscle tension
- Avoid long-term analgesics
- Enhance restorative sleep (low-dose antidepressants)
- Increase general fitness and health
Examples of antidepressants that cant be used in fibromyalgia management
- Tricyclics (such as Amitriptyline)
- Pregabalin (Lyrica)
Sleep management in rheumatic disease
- Sleep hygiene
- Behavior therapy
- Pharmacotherapy
Paget’s Disease high-yield facts
- Etiology unknown
- 15-30% have family history of the disease
- Prevalence is high in the United States, Australia, and New Zealand, but the disease is rare in Asia
- Occurs in 1-3% of patients over the age of 45
- Abnormal bone resorption and new bone formation (pain and fractures; misshapen bones)
- Have elevated alkaline phosphatase blood levels
- Most patients require no treatment; clinical therapeutics depends on symptomotology
- Typically localized (effects one or a few bones) versus osteoporosis which is usually generalized
Treatment for Paget’s Disease
- No cure
- Symptoms are treated with bisphosphonates (i.e. Fosamax)
and calcitonin
(a hormone that lowers calcium and phosphate concentrations in plasma and inhibits bone resorption)
Tumor-like conditions of bone
- Paget’s disease – a lytic lesion of bone; a condition probably of viral origin
- The pseudocyst is accentuated by the increased density of the trabeculae
Osteoporosis
- Decreased bone mass (brittle bone)
Osteomalacia
- Decreased bone mineralization (soft bone)
Osteopetrosis
- Hard bone
Osteopenia
- Radiographic term that describes decreased bone density
Causes of generalized osteoporosis
- Aging (accelerated in women because decreased estrogen production following menopause)
- Steroids
- Heparin (i.e. osteonecrosis)
- Malnutrition
- Hyperparathyroidism and other endocrine abnormalities
- Osteogenesis imperfecta (congenital; “brittle bone disease”; Blue sclerae)
Causes of focal osteoporosis
- Disuse (e.g. after trauma or due to paralysis)
- Osteomyelitis
- RSD
- Tumor
Management of osteoporosis (physical therapy)
- Brace for acute pain management
- Elevate gait and balance, provide assistive devices if necessary
- Weight-bearing exercise, fall techniques
- Back protection, lifting restrictions
- Improve balance, muscle strength, and tone
Muscles to focus on strengthening in osteoporosis
- Paraspinal muscle stretching and strengthening
- Pelvic girdle and abdominal muscle strengthening
Current treatments for osteoporosis
Bisphosphonates
- Alendronate (Fosamax), a weekly pill
- Risedronate (Actonel), a weekly or monthly pill
- Ibandronate (Boniva), a monthly pill or quarterly intravenous (IV) infusion
- Zoledronic acid (Reclast), an annualIVinfusion
- Denosumab (Prolia, Xgeva): Shallow injection q 6 month
Causes of secondary osteoporosis
- Endocrine disorders
- Malabsorption, malnutrition
- Hepatic or renal dysfunction
- Genetic disorders
- Systemic inflammatory diseases
- Psychiatric disorders
- Malignancies
Endocrine disorders that may cause secondary osteoporosis
- Cushing’s Disease
- Hyperparathyroidism
- Diabetes mellitus
- Prolactinoma
- Hypogonadism
Genetic disorders that may cause secondary osteoporosis
- Osteogenesis imperfecta
Systemic inflammatory diseases that may cause secondary osteoporosis
- Rheumatoid arthritis
Psychiatric disorders that may cause secondary osteoporosis
- Anorexia
- Depression
Malignancies that may cause secondary osteoporosis
- Multiple myeloma
Drugs that may cause secondary osteoporosis
- Glucocorticoids
- Excess thyroid replacement
- Heparin
- Methotrexate?
- Cyclosporin A?
Potential utility of bone density measurement
- Assess future fracture risk
- Confirm diagnosis of osteoporosis
- Monitor effects of treatment
- Assess rate of bone loss
- Enhance patient acceptance of and compliance with treatment
Peak bone mineral density (BMD) is usually achieved by
- The middle of the third decade of life
Bone mineral density z-score represents
- # SD above/below the mean compared with age/sex-matched population